Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of Injectable Drug Delivery Formulation market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Injectable Drug Delivery Formulationmarket, defines the market attractiveness level of Injectable Drug Delivery Formulation market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Injectable Drug Delivery Formulation industry, describes the types of Injectable Drug Delivery Formulation market, the applications of major players and the market size, and deeply analyzes the current situation of the global Injectable Drug Delivery Formulation market and the development prospects and opportunities of Injectable Drug Delivery Formulation industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Injectable Drug Delivery Formulation market in Chapter 13.
By Player:
Sandoz (Germany)
Eli Lilly and Company (US)
Schott AG (Germany)
Pfizer, Inc (US)
Teva Pharmaceutical Industries Ltd (Israel)
Gerresheimer AG (Germany)
Baxter International Inc (US)
Becton, Dickinson and Company (US)
By Type:
Conventional Drug Delivery Formulations
Novel Drug Delivery Formulations
Long-acting Formulations
By End-User:
Autoimmune Diseases
Hormonal Disorders
Oncology
Orphan Diseases
Others
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Injectable Drug Delivery Formulation Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Injectable Drug Delivery Formulation Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Injectable Drug Delivery Formulation Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Injectable Drug Delivery Formulation Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Injectable Drug Delivery Formulation Market Analysis and Outlook to 2022
-
7.1 Global Injectable Drug Delivery Formulation Consumption (2017-2022)
-
7.2 United States Injectable Drug Delivery Formulation Consumption (2017-2022)
-
7.3 Europe Injectable Drug Delivery Formulation Consumption (2017-2022)
-
7.4 China Injectable Drug Delivery Formulation Consumption (2017-2022)
-
7.5 Japan Injectable Drug Delivery Formulation Consumption (2017-2022)
-
7.6 India Injectable Drug Delivery Formulation Consumption (2017-2022)
-
7.7 South Korea Injectable Drug Delivery Formulation Consumption (2017-2022)
8 Region and Country-wise Injectable Drug Delivery Formulation Market Analysis and Outlook to 2028
-
8.1 Global Injectable Drug Delivery Formulation Consumption Forecast (2022-2028)
-
8.2 United States Injectable Drug Delivery Formulation Consumption Forecast (2022-2028)
-
8.3 Europe Injectable Drug Delivery Formulation Consumption Forecast (2022-2028)
-
8.4 China Injectable Drug Delivery Formulation Consumption Forecast (2022-2028)
-
8.5 Japan Injectable Drug Delivery Formulation Consumption Forecast (2022-2028)
-
8.6 India Injectable Drug Delivery Formulation Consumption Forecast (2022-2028)
-
8.7 South Korea Injectable Drug Delivery Formulation Consumption Forecast (2022-2028)
9 Global Injectable Drug Delivery Formulation Market Outlook by Types and Applications to 2022
-
9.1 Global Injectable Drug Delivery Formulation Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Conventional Drug Delivery Formulations Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Novel Drug Delivery Formulations Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Long-acting Formulations Consumption and Growth Rate (2017-2022)
-
9.2 Global Injectable Drug Delivery Formulation Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Autoimmune Diseases Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Hormonal Disorders Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Oncology Consumption and Growth Rate (2017-2022)
-
9.2.4 Global Orphan Diseases Consumption and Growth Rate (2017-2022)
-
9.2.5 Global Others Consumption and Growth Rate (2017-2022)
10 Global Injectable Drug Delivery Formulation Market Outlook by Types and Applications to 2028
-
10.1 Global Injectable Drug Delivery Formulation Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Conventional Drug Delivery Formulations Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Novel Drug Delivery Formulations Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global Long-acting Formulations Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Injectable Drug Delivery Formulation Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Autoimmune Diseases Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Hormonal Disorders Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Oncology Consumption Forecast and Growth Rate (2022-2028)
-
10.2.4 Global Orphan Diseases Consumption Forecast and Growth Rate (2022-2028)
-
10.2.5 Global Others Consumption Forecast and Growth Rate (2022-2028)
11 Global Injectable Drug Delivery Formulation Import and Export Analysis (Top 5 Countries)
-
11.1 Global Injectable Drug Delivery Formulation Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Injectable Drug Delivery Formulation Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Injectable Drug Delivery Formulation Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Injectable Drug Delivery Formulation Market Competitive Analysis
-
14.1 Sandoz (Germany)
-
14.1.1 Sandoz (Germany) Company Details
-
14.1.2 Sandoz (Germany) Injectable Drug Delivery Formulation Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Sandoz (Germany) Injectable Drug Delivery Formulation Product and Service
-
14.2 Eli Lilly and Company (US)
-
14.2.1 Eli Lilly and Company (US) Company Details
-
14.2.2 Eli Lilly and Company (US) Injectable Drug Delivery Formulation Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Eli Lilly and Company (US) Injectable Drug Delivery Formulation Product and Service
-
14.3 Schott AG (Germany)
-
14.3.1 Schott AG (Germany) Company Details
-
14.3.2 Schott AG (Germany) Injectable Drug Delivery Formulation Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Schott AG (Germany) Injectable Drug Delivery Formulation Product and Service
-
14.4 Pfizer, Inc (US)
-
14.4.1 Pfizer, Inc (US) Company Details
-
14.4.2 Pfizer, Inc (US) Injectable Drug Delivery Formulation Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Pfizer, Inc (US) Injectable Drug Delivery Formulation Product and Service
-
14.5 Teva Pharmaceutical Industries Ltd (Israel)
-
14.5.1 Teva Pharmaceutical Industries Ltd (Israel) Company Details
-
14.5.2 Teva Pharmaceutical Industries Ltd (Israel) Injectable Drug Delivery Formulation Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Teva Pharmaceutical Industries Ltd (Israel) Injectable Drug Delivery Formulation Product and Service
-
14.6 Gerresheimer AG (Germany)
-
14.6.1 Gerresheimer AG (Germany) Company Details
-
14.6.2 Gerresheimer AG (Germany) Injectable Drug Delivery Formulation Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Gerresheimer AG (Germany) Injectable Drug Delivery Formulation Product and Service
-
14.7 Baxter International Inc (US)
-
14.7.1 Baxter International Inc (US) Company Details
-
14.7.2 Baxter International Inc (US) Injectable Drug Delivery Formulation Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 Baxter International Inc (US) Injectable Drug Delivery Formulation Product and Service
-
14.8 Becton, Dickinson and Company (US)
-
14.8.1 Becton, Dickinson and Company (US) Company Details
-
14.8.2 Becton, Dickinson and Company (US) Injectable Drug Delivery Formulation Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 Becton, Dickinson and Company (US) Injectable Drug Delivery Formulation Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Injectable Drug Delivery Formulation
-
Figure Injectable Drug Delivery Formulation Picture
-
Table Global Injectable Drug Delivery Formulation Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Injectable Drug Delivery Formulation Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Injectable Drug Delivery Formulation Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Injectable Drug Delivery Formulation Consumption by Country (2017-2022)
-
Figure United States Injectable Drug Delivery Formulation Consumption and Growth Rate (2017-2022)
-
Table Europe Injectable Drug Delivery Formulation Consumption and Growth Rate (2017-2022)
-
Figure China Injectable Drug Delivery Formulation Consumption and Growth Rate (2017-2022)
-
Figure Japan Injectable Drug Delivery Formulation Consumption and Growth Rate (2017-2022)
-
Figure India Injectable Drug Delivery Formulation Consumption and Growth Rate (2017-2022)
-
Figure South Korea Injectable Drug Delivery Formulation Consumption and Growth Rate (2017-2022)
-
Figure Global Injectable Drug Delivery Formulation Consumption Forecast by Country (2022-2028)
-
Figure United States Injectable Drug Delivery Formulation Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Injectable Drug Delivery Formulation Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Injectable Drug Delivery Formulation Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Injectable Drug Delivery Formulation Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Injectable Drug Delivery Formulation Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Injectable Drug Delivery Formulation Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Conventional Drug Delivery Formulations Consumption and Growth Rate (2017-2022)
-
Figure Global Novel Drug Delivery Formulations Consumption and Growth Rate (2017-2022)
-
Figure Global Long-acting Formulations Consumption and Growth Rate (2017-2022)
-
Figure Global Autoimmune Diseases Consumption and Growth Rate (2017-2022)
-
Figure Global Hormonal Disorders Consumption and Growth Rate (2017-2022)
-
Figure Global Oncology Consumption and Growth Rate (2017-2022)
-
Figure Global Orphan Diseases Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global Conventional Drug Delivery Formulations Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Novel Drug Delivery Formulations Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Long-acting Formulations Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Autoimmune Diseases Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hormonal Disorders Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Oncology Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Orphan Diseases Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Injectable Drug Delivery Formulation Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Injectable Drug Delivery Formulation Export by Region (Top 5 Countries) (2017-2028)
-
Table Sandoz (Germany) (Foundation Year, Company Profile and etc.)
-
Table Sandoz (Germany) Injectable Drug Delivery Formulation Sales, Price, Value and Gross Profit (2017-2022)
-
Table Sandoz (Germany) Injectable Drug Delivery Formulation Product and Service
-
Table Eli Lilly and Company (US) (Foundation Year, Company Profile and etc.)
-
Table Eli Lilly and Company (US) Injectable Drug Delivery Formulation Sales, Price, Value and Gross Profit (2017-2022)
-
Table Eli Lilly and Company (US) Injectable Drug Delivery Formulation Product and Service
-
Table Schott AG (Germany) (Foundation Year, Company Profile and etc.)
-
Table Schott AG (Germany) Injectable Drug Delivery Formulation Sales, Price, Value and Gross Profit (2017-2022)
-
Table Schott AG (Germany) Injectable Drug Delivery Formulation Product and Service
-
Table Pfizer, Inc (US) (Foundation Year, Company Profile and etc.)
-
Table Pfizer, Inc (US) Injectable Drug Delivery Formulation Sales, Price, Value and Gross Profit (2017-2022)
-
Table Pfizer, Inc (US) Injectable Drug Delivery Formulation Product and Service
-
Table Teva Pharmaceutical Industries Ltd (Israel) (Foundation Year, Company Profile and etc.)
-
Table Teva Pharmaceutical Industries Ltd (Israel) Injectable Drug Delivery Formulation Sales, Price, Value and Gross Profit (2017-2022)
-
Table Teva Pharmaceutical Industries Ltd (Israel) Injectable Drug Delivery Formulation Product and Service
-
Table Gerresheimer AG (Germany) (Foundation Year, Company Profile and etc.)
-
Table Gerresheimer AG (Germany) Injectable Drug Delivery Formulation Sales, Price, Value and Gross Profit (2017-2022)
-
Table Gerresheimer AG (Germany) Injectable Drug Delivery Formulation Product and Service
-
Table Baxter International Inc (US) (Foundation Year, Company Profile and etc.)
-
Table Baxter International Inc (US) Injectable Drug Delivery Formulation Sales, Price, Value and Gross Profit (2017-2022)
-
Table Baxter International Inc (US) Injectable Drug Delivery Formulation Product and Service
-
Table Becton, Dickinson and Company (US) (Foundation Year, Company Profile and etc.)
-
Table Becton, Dickinson and Company (US) Injectable Drug Delivery Formulation Sales, Price, Value and Gross Profit (2017-2022)
-
Table Becton, Dickinson and Company (US) Injectable Drug Delivery Formulation Product and Service
-
